Valery Sudakin
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, Genomics and Chromatin Dynamics, Epigenetics and DNA Methylation
Most-Cited Works
- → Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2(2001)905 cited
- → The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.(1995)755 cited
- → Human Bubr1 Is a Mitotic Checkpoint Kinase That Monitors Cenp-E Functions at Kinetochores and Binds the Cyclosome/APC(1999)380 cited
- → Components of a system that ligates cyclin to ubiquitin and their regulation by the protein kinase cdc2.(1994)233 cited
- → Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase.(1995)198 cited
- → ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism(2007)108 cited
- Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity.(2002)
- → Targeting Mitosis for Anti-Cancer Therapy(2007)58 cited
- → Binding of Activated Cyclosome to p13(1997)56 cited
- → Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors(2011)54 cited